Hot Features
プレミアム
Clearside Biomedical Inc (CLSD)
NASDAQ
ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye. The product candidates of the company focus on a disease affecting the retina and aim to restore or improve visual functio... Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye. The product candidates of the company focus on a disease affecting the retina and aim to restore or improve visual function primarily by reducing the macular edema associated with several diseases affecting vision. 詳細を表示
- Upcoming Presentations at Angiogenesis and Macula Society Conferences to Feature CLS-AX Sub-Group Analyses from ODYSSEY Wet AMD Trial - - CLS-AX Targets Flexible Dosing of Biologics with...
- ARCATUS®, Branded as XIPERE® in the U.S., is the First Globally Approved Suprachoroidal Therapy - - Continued Global Expansion of Clearside’s Suprachoroidal Space Injection Platform Featuring...
ALPHARETTA, Ga., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through...
- Commercial, Clinical and Regulatory Expertise Establish Clearside as the Leader in Suprachoroidal Delivery - - Multiple Events at Asia-Pacific Vitreo-Retina Society Congress Highlighting...
- Recent ODYSSEY Phase 2b Trial of Suprachoroidal CLS-AX in Wet AMD Achieved All Primary and Secondary Outcomes - - Positive Topline Results Support Advancing CLS-AX to Phase 3 Targeting a...
- Partnership Creates New Opportunities to Address Unmet Needs Related to Posterior Segment Eye Diseases in China - - Agreement Provides Additional Validation for Clearside’s Suprachoroidal Space...
ALPHARETTA, Ga., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through...
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0348 | 3.80286307507 | 0.9151 | 0.96 | 0.9 | 125814 | 0.92759422 | CS |
| 4 | -0.0051 | -0.534031413613 | 0.955 | 1.0176 | 0.9 | 135041 | 0.94672693 | CS |
| 12 | -0.2101 | -18.1120689655 | 1.16 | 1.16 | 0.801 | 248083 | 0.98965602 | CS |
| 26 | -0.1901 | -16.6754385965 | 1.14 | 1.65 | 0.801 | 487841 | 1.18245924 | CS |
| 52 | -0.4001 | -29.637037037 | 1.35 | 2.12 | 0.801 | 381005 | 1.2787172 | CS |
| 156 | -0.9201 | -49.2032085561 | 1.87 | 2.85 | 0.650101 | 313632 | 1.46565149 | CS |
| 260 | -2.6001 | -73.2422535211 | 3.55 | 7.73 | 0.650101 | 510550 | 2.979775 | CS |
| 銘柄コード | 株価 | 出来高 |
|---|---|---|
| TCTMTCTM Kids IT Education Inc | US$ 0.764 (321.87%) | 729.72M |
| NVDANVIDIA Corporation | US$ 120.07 (-3.67%) | 388.54M |
| RIMEAlgorhythm Holdings Inc | US$ 0.02565 (5.12%) | 338.75M |
| BHATBlue Hat Interactive Entertainment Technology | US$ 0.0355 (-11.25%) | 236.29M |
| CLEUChina Liberal Education Holdings Ltd | US$ 0.1938 (30.77%) | 234.8M |
georgie18
1月前
Invest-in-America
4月前
Awl416
4月前
BBANBOB
4月前
BBANBOB
5月前
Monksdream
5月前
Monksdream
7月前
Monksdream
9月前
BBANBOB
10月前
BBANBOB
11月前
BBANBOB
11月前
jhdf51
11月前
BBANBOB
11月前
jhdf51
11月前
BBANBOB
11月前
BBANBOB
11月前
jhdf51
11月前
BBANBOB
11月前
BBANBOB
11月前
BBANBOB
11月前
Monksdream
11月前
Monksdream
11月前
glenn1919
11月前
BBANBOB
11月前
Monksdream
11月前
Monksdream
11月前
BBANBOB
1年前
BBANBOB
1年前
BBANBOB
1年前
Monksdream
1年前
Monksdream
1年前
Monksdream
1年前
Monksdream
1年前
heyitsmeagain
2年前
heyitsmeagain
2年前
BBANBOB
3年前
BBANBOB
3年前
BBANBOB
3年前
BBANBOB
3年前
jhdf51
3年前
BBANBOB
3年前
jhdf51
3年前
BBANBOB
3年前
jhdf51
3年前
BBANBOB
3年前
BBANBOB
3年前
BBANBOB
3年前
BBANBOB
3年前
BBANBOB
3年前
BBANBOB
3年前
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
